US FDA Panel To Take Up Lutonix DCB Catheter For Lower-Leg Use Next Month
If approved, the device will be the first drug-coated balloon indicated specifically for use in arteries below the knee.
You may also be interested in...
Shifting trial design and missing data, plus little evidence of benefit, worked against the paclitaxel-coated balloon, panelists and US FDA speakers said.
SELUTION SLR is the first drug-eluting balloon accepted by the FDA as part of its breakthrough program, according to the company.
Medtech Insight spoke to attorney Greg Dadika about mass tort litigation, including industry trends, how to find the right law firm, and when it’s the right time to settle a suit.